These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12638838)

  • 21. [The chronic complications of diabetes].
    Sanmartín EF
    Rev Enferm; 1990 May; 13(141 Suppl):14-8. PubMed ID: 2359931
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of pancreas transplantation on diabetic secondary complications and quality of life.
    Landgraf R
    Diabetologia; 1996 Dec; 39(12):1415-24. PubMed ID: 8960821
    [No Abstract]   [Full Text] [Related]  

  • 23. ABC of arterial and venous disease: vascular complications of diabetes.
    Donnelly R; Emslie-Smith AM; Gardner ID; Morris AD
    BMJ; 2000 Apr; 320(7241):1062-6. PubMed ID: 10764371
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of pancreatic transplantation on diabetic complications.
    Munda R; First MR; Kranias G; Alexander JW
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2865-6. PubMed ID: 2650389
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complications of diabetes mellitus].
    Goto Y
    Nihon Naika Gakkai Zasshi; 1985 Dec; 74(12):1635-51. PubMed ID: 3831189
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic complications of non-insulin-dependent diabetes.
    Watkins PJ; Grenfell A; Edmonds M
    Diabet Med; 1987; 4(4):293-6. PubMed ID: 2956037
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term complications of type I (insulin-dependent) diabetes mellitus.
    Rosenbloom AL
    Pediatr Ann; 1983 Sep; 12(9):668-84. PubMed ID: 6355999
    [No Abstract]   [Full Text] [Related]  

  • 28. Late complications of diabetes mellitus: risk factors in patients on sulfonylureas for more than 10 years.
    Hoshi M; Fujita S
    Jpn J Med; 1991; 30(6):616-7. PubMed ID: 1798228
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
    Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
    Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
    Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
    Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M; Ibraheem W; Iwuala S; Audu M; Kolawole B
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Type-2 diabetes mellitus as a cause of disability].
    Piechota G; Małkiewicz J; Karwat ID
    Przegl Epidemiol; 2004; 58(4):677-82. PubMed ID: 15810510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L; Hulman A; Carstensen B; Charles M; Jørgensen ME; Witte DR
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
    Das AK; Mithal A; Kumar KMP; Unnikrishnan AG; Kalra S; Thacker H; Sethi B; Ghosh R; Mathew A; Chodankar D; Mohanasundaram S; Menon SK; Trivedi C; Naqvi M; Kanade V; Salvi V; Chatterjee G; Rais N; Wangnoo SK; Chowdhury S; Zargar AH; Joshi S
    Diabet Med; 2020 May; 37(5):885-892. PubMed ID: 31691356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Professional recommendations for follow-up of the type 2 diabetic patient excluding the follow-up of complications. National Agency for the Accreditation and Evaluation of Health].
    J Mal Vasc; 1999 Jun; 24(3):239-44. PubMed ID: 10467537
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hypertension and abnormal lipid metabolism].
    Nishimura H
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():258-62. PubMed ID: 23156404
    [No Abstract]   [Full Text] [Related]  

  • 37. Banting lecture 1986. Does a common mechanism induce the diverse complications of diabetes?
    Winegrad AI
    Diabetes; 1987 Mar; 36(3):396-406. PubMed ID: 3026877
    [No Abstract]   [Full Text] [Related]  

  • 38. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
    Valencia WM; Florez H
    BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Arterial hypertension in diabetes mellitus].
    Tiengo A
    G Clin Med; 1990 Jan; 71(1):3-6, 10-6. PubMed ID: 2142112
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of Microvascular Complications of Diabetes.
    Crasto W; Patel V; Davies MJ; Khunti K
    Endocrinol Metab Clin North Am; 2021 Sep; 50(3):431-455. PubMed ID: 34399955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.